Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 22, Issue 1, Pages 1-26
Publisher
Informa UK Limited
Online
2016-12-08
DOI
10.1080/14728214.2017.1269743
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials
- (2016) Paul M. Ridker et al. AMERICAN HEART JOURNAL
- Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
- (2016) Marc S. Sabatine et al. AMERICAN HEART JOURNAL
- From Lipids to Inflammation
- (2016) Michael D. Shapiro et al. CIRCULATION RESEARCH
- Inflammatory cytokines in atherosclerosis: current therapeutic approaches
- (2016) Dimitris Tousoulis et al. EUROPEAN HEART JOURNAL
- Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction
- (2016) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery
- (2016) Barbara E. Stähli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
- (2016) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- CETP Inhibition in CVD Prevention: an Actual Appraisal
- (2016) Belinda Di Bartolo et al. Current Cardiology Reports
- Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial
- (2015) Stephen J. Nicholls et al. AMERICAN HEART JOURNAL
- Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia
- (2015) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)
- (2015) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Novel anti-inflammatory therapies for the treatment of atherosclerosis
- (2015) Razi Khan et al. ATHEROSCLEROSIS
- A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome
- (2015) Juan Gaztanaga et al. ATHEROSCLEROSIS
- Lipoprotein(a) – An independent causal risk factor for cardiovascular disease and current therapeutic options
- (2015) Ursula Kassner et al. ATHEROSCLEROSIS SUPPLEMENTS
- Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-ITCLINICAL PERSPECTIVES
- (2015) Erin A. Bohula et al. CIRCULATION
- Effect of Bile Acid Sequestrants on the Risk of Cardiovascular EventsCLINICAL PERSPECTIVE
- (2015) Stephanie Ross et al. Circulation-Cardiovascular Genetics
- Pharmacogenomic Determinants of the Cardiovascular Effects of DalcetrapibCLINICAL PERSPECTIVE
- (2015) Jean-Claude Tardif et al. Circulation-Cardiovascular Genetics
- Targeting Lipoprotein (a): an Evolving Therapeutic Landscape
- (2015) Lillian C. Man et al. Current Atherosclerosis Reports
- Inflammation and plaque vulnerability
- (2015) G. K. Hansson et al. JOURNAL OF INTERNAL MEDICINE
- Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
- (2015) G Kees Hovingh et al. LANCET
- PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Anti-inflammatory therapies for atherosclerosis
- (2015) Magnus Bäck et al. Nature Reviews Cardiology
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Bile Acid Sequestrants on the Risk of Cardiovascular EventsCLINICAL PERSPECTIVE
- (2015) Stephanie Ross et al. Circulation-Cardiovascular Genetics
- Pharmacogenomic Determinants of the Cardiovascular Effects of DalcetrapibCLINICAL PERSPECTIVE
- (2015) Jean-Claude Tardif et al. Circulation-Cardiovascular Genetics
- Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
- (2014) Gregory G. Schwartz et al. AMERICAN HEART JOURNAL
- Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel
- (2014) Todd J. Anderson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
- (2014) Peter Libby et al. CIRCULATION RESEARCH
- Increased Benefit of Interleukin-1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients With Coronary Artery Disease and Coexisting Rheumatoid Arthritis
- (2014) Ignatios Ikonomidis et al. Circulation-Cardiovascular Imaging
- Colchicine for Secondary Prevention of Cardiovascular Disease
- (2014) Stefan M. Nidorf et al. Current Atherosclerosis Reports
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
- (2014) A. C. Morton et al. EUROPEAN HEART JOURNAL
- Anti-inflammatory therapies for cardiovascular disease
- (2014) P. M. Ridker et al. EUROPEAN HEART JOURNAL
- Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
- (2014) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome
- (2014) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
- (2014) Jennifer G. Robinson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
- (2014) S. Matthijs Boekholdt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance
- (2014) Erik Stroes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anti-PCSK9 Monotherapy for Hypercholesterolemia
- (2014) Michael J. Koren et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial
- (2014) L Kristin Newby et al. LANCET
- Lipid lowering with PCSK9 inhibitors
- (2014) Razvan T. Dadu et al. Nature Reviews Cardiology
- A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
- (2014) Dirk J. Blom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
- (2014) D. Keene et al. BMJ-British Medical Journal
- Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application
- (2014) Fabian Linden et al. Frontiers in Physiology
- Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern
- (2013) M. von Dryander et al. ATHEROSCLEROSIS SUPPLEMENTS
- Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease
- (2013) Josef Leebmann et al. CIRCULATION
- Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk
- (2013) Amit V. Khera et al. CIRCULATION
- Cardiovascular Pharmacogenomics: Expectations and Practical Benefits
- (2013) R M Turner et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Emerging Anti-inflammatory Therapies for Atherosclerosis
- (2013) François Roubille et al. CURRENT PHARMACEUTICAL DESIGN
- Emerging anti-inflammatory drugs for atherosclerosis
- (2013) Jeremy P Berman et al. EXPERT OPINION ON EMERGING DRUGS
- Inflammation and the heart – prime time for new therapeutic approaches
- (2013) François Roubille et al. EXPERT OPINION ON EMERGING DRUGS
- Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction
- (2013) Jean-Claude Tardif et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes
- (2013) John J. Albers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a), Cardiovascular Disease, and Contemporary Management
- (2013) Terry A. Jacobson MAYO CLINIC PROCEEDINGS
- Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
- (2013) Peter Libby NEW ENGLAND JOURNAL OF MEDICINE
- Use of Niacin in the United States and Canada
- (2013) Cynthia A. Jackevicius et al. JAMA Internal Medicine
- Clinical Value of Drugs Targeting Inflammation for the Management of Coronary Artery Disease
- (2012) Valérie Duchatelle et al. CANADIAN JOURNAL OF CARDIOLOGY
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia
- (2012) Frederick Raal et al. CIRCULATION
- Lipoprotein(a)
- (2012) Joseph B. Dubé et al. CURRENT OPINION IN LIPIDOLOGY
- Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
- (2012) Alexios S. Antonopoulos et al. CURRENT PHARMACEUTICAL DESIGN
- Antisense oligonucleotides for the treatment of dyslipidaemia
- (2012) Maartje E. Visser et al. EUROPEAN HEART JOURNAL
- Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients
- (2012) David Sullivan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease
- (2012) Erik Ingelsson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout
- (2012) DARIA B. CRITTENDEN et al. JOURNAL OF RHEUMATOLOGY
- EFFECT OF MIPOMERSEN ON LIPOPROTEIN(A) IN PATIENTS WITH HYPERCHOLESTEROLEMIA ACROSS FOUR PHASE III STUDIES
- (2012) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy
- (2012) James M. McKenney et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study
- (2012) Michael J Koren et al. LANCET
- Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
- (2012) Robert P Giugliano et al. LANCET
- Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
- (2012) Evan A Stein et al. LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia
- (2012) Eli M. Roth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin Therapy and the Risk of Intracerebral Hemorrhage
- (2012) James S. McKinney et al. STROKE
- Effects of p38 Mitogen-Activated Protein Kinase Inhibition on Vascular and Systemic Inflammation in Patients With Atherosclerosis
- (2012) Maysoon Elkhawad et al. JACC-Cardiovascular Imaging
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
- (2011) Renata Micha et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region
- (2011) Jim Gilbert et al. AMERICAN JOURNAL OF CARDIOLOGY
- A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis
- (2011) A.D. Protogerou et al. ATHEROSCLEROSIS
- Imaging Biomarkers in Atherosclerosis Trials
- (2011) Jean-Claude Tardif et al. Circulation-Cardiovascular Imaging
- Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials
- (2011) E. Braunwald EUROPEAN HEART JOURNAL
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Treatment With Methotrexate Inhibits Atherogenesis in Cholesterol-Fed Rabbits
- (2011) Adriana Bulgarelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Progress and challenges in translating the biology of atherosclerosis
- (2011) Peter Libby et al. NATURE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
- (2010) J. D. Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of p38 Mitogen-Activated Protein Kinase Reduces Inflammation After Coronary Vascular Injury in Humans
- (2010) Lea Sarov-Blat et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease
- (2010) Ziad Mallat et al. CIRCULATION
- Inflammation in Atherosclerosis:
- (2010) Peter Libby et al. CIRCULATION JOURNAL
- Treatment With 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients With Recent Acute Coronary Syndrome
- (2010) Jean-Claude Tardif et al. Circulation-Cardiovascular Imaging
- A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
- (2010) Jean-Claude Tardif et al. Circulation-Cardiovascular Interventions
- Strategies for proprotein convertase subtilisin kexin 9 modulation: a perspective on recent patents
- (2010) Marianne Abifadel et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients
- (2010) Robert S. Rosenson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia
- (2010) Hans J. Avis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques
- (2010) Alessandra Bitto et al. JOURNAL OF VASCULAR SURGERY
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Monocytes in atherosclerosis: subsets and functions
- (2010) Kevin J. Woollard et al. Nature Reviews Cardiology
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease
- (2009) Marianne Abifadel et al. HUMAN MUTATION
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation
- (2009) Steve Poirier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
- (2009) PAUL M. RIDKER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
- (2009) S. L. Westlake et al. RHEUMATOLOGY
- Inflammation and Plaque Vulnerability
- (2008) Prediman K. Shah CARDIOVASCULAR DRUGS AND THERAPY
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
- Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
- (2008) Patrick W. Serruys et al. CIRCULATION
- Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
- (2008) Jean-Claude Tardif et al. LANCET
- Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
- (2008) Robert L Wilensky et al. NATURE MEDICINE
- Mechanotransduction in vascular physiology and atherogenesis
- (2008) Cornelia Hahn et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
- (2008) John J.P. Kastelein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
- (2008) Frederick F Samaha et al. Nature clinical practice. Cardiovascular medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started